|
Index of reports
> Cases resulting in disability (13)
Below is the selection of adverse event reports related to Trileptal (Oxcarbazepine) that includes cases resulting in disability.
Adverse event in 20 year old male receiving Trileptal (Oxcarbazepine)
Reported by a physician from France on 2007-10-30
Patient: 20 year old male, weighing 70.0 kg (154.0 pounds)
Adverse reactions / side effects: Respiratory Disorder, Blood Creatine Phosphokinase Increased, High Density Lipoprotein Increased, Lymphadenopathy, Urinary Incontinence, Visual Acuity Reduced, Ulcerative Keratitis, Pyrexia, Transaminases Increased, Obstructive Uropathy, C-Reactive Protein Increased, Acute Respiratory Distress Syndrome, Dermatitis Bullous, Mucous Membrane Disorder, Cough, Mechanical Ventilation, Back Pain, Dysphagia, Toxic Epidermal Necrolysis, Corneal Opacity, Prothrombin Time Ratio Decreased, Blood Creatine Phosphokinase MB Increased, Heart Rate Decreased, Rash Erythematous, Ureteral Catheterisation, Renal Colic, Skin Exfoliation, Eye Discharge, Corneal Neovascularisation, Symblepharon, Scab, Intubation, Nephrolithiasis, Corneal Transplant, Microlithiasis, Bone Marrow Failure, Thrombocytopenia, Renal Failure Acute, Catheter Related Complication, Depilation, Cataract, Iris Adhesions, Lacrimation Decreased, Alopecia, Lithotripsy, Asthenia, Leukopenia
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Depakene
Dosage: 1.6 g daily
Indication: Partial Seizures
End date: 2004-11-22
Trileptal
Dosage: 600 mg, bid
Administration route: Oral
Indication: Partial Seizures
Start date: 2005-02-14
End date: 2005-02-21
Depakene
Dosage: 1 g daily
Administration route: Oral
Indication: Partial Seizures
Start date: 2004-11-23
End date: 2004-11-23
Depakene
Dosage: 1.5 g daily
Start date: 2004-11-24
End date: 2005-02-21
Aspegic 325
Indication: Influenza Like Illness
Start date: 2005-02-01
Other drugs received by patient: Rivotril
Adverse event in 30 year old female receiving Trileptal (Oxcarbazepine)
Reported by a physician from China on 2007-10-26
Patient: 30 year old female
Adverse reactions / side effects: Osteonecrosis
Adverse event resulted in: disablity
Suspect drug(s):
Trileptal (Oxcarbazepine)
Adverse event in 15 year old female receiving Trileptal (Oxcarbazepine)
Reported by a physician from France on 2007-10-02
Patient: 15 year old female, weighing 41.0 kg (90.2 pounds)
Adverse reactions / side effects: Blood Pressure Systolic Decreased, Dyspnoea, Fatigue, Amnesia
Adverse event resulted in: disablity
Suspect drug(s):
Trileptal
Dosage: 150 mg, bid
Administration route: Oral
Indication: Partial Seizures
Start date: 2007-09-06
End date: 2007-09-08
Trileptal
Dosage: 150 mg am, 300 mg evening
Administration route: Oral
Start date: 2007-09-09
Adverse event in 31 year old female receiving Trileptal (Oxcarbazepine)
Reported by a health professional (non-physician/pharmacist) from Colombia on 2007-06-13
Patient: 31 year old female
Adverse reactions / side effects: Mania, Systemic Lupus Erythematosus Rash, Inflammation
Adverse event resulted in: disablity
Suspect drug(s):
Trileptal (Oxcarbazepine)
Other drugs received by patient: Clonazepam; Valproate Magnesium
Adverse event in 31 year old female receiving Trileptal (Oxcarbazepine)
Reported by a health professional (non-physician/pharmacist) from Colombia on 2007-06-11
Patient: 31 year old female
Adverse reactions / side effects: Mania, Rheumatoid Arthritis, Systemic Lupus Erythematosus Rash
Adverse event resulted in: disablity
Suspect drug(s):
Trileptal (Oxcarbazepine)
Other drugs received by patient: Clonazepam; Valproate Magnesium
Adverse event in 49 year old female receiving Trileptal (Oxcarbazepine)
Reported by a physician from Brazil on 2007-06-04
Patient: 49 year old female
Adverse reactions / side effects: Optic Nerve Disorder, Drug Ineffective, Impaired Work Ability, Chills, Fear, Visual Field Tests Abnormal, Visual Acuity Reduced, Disorientation, Headache, Speech Disorder, Diplopia, Malaise, Social Avoidant Behaviour, Tongue Disorder, Retinal Disorder, Eye Movement Disorder, Aura, Crying, Corrective Lens User, Anxiety, Visual Disturbance, Abnormal Sensation in Eye, Petit MAL Epilepsy, Feeling Abnormal, Blindness
Adverse event resulted in: disablity
Suspect drug(s):
Trileptal
Dosage: 600 mg, tid
Indication: Petit MAL Epilepsy
Start date: 2007-02-14
Trileptal
Dosage: unk, unk
Administration route: Oral
Start date: 1982-01-01
Oxcarbazepine
Dosage: 2df/day
Other drugs received by patient: Topamax; Rivotril; Paroxetine (Pondera)
Adverse event in 20 year old male receiving Trileptal (Oxcarbazepine)
Reported by a consumer/non-health professional from France on 2007-05-17
Patient: 20 year old male, weighing 70.0 kg (154.0 pounds)
Adverse reactions / side effects: High Density Lipoprotein Increased, Blood Creatine Phosphokinase Increased, Lymphadenopathy, Respiratory Disorder, Corneal Neovascularisation, Skin Exfoliation, Symblepharon, Scab, Intubation, Ulcerative Keratitis, Pyrexia, Transaminases Increased, Corneal Transplant, C-Reactive Protein Increased, Dermatitis Bullous, Bone Marrow Failure, Acute Respiratory Distress Syndrome, Mucous Membrane Disorder, Thrombocytopenia, Renal Disorder, Dysphagia, Depilation, Toxic Epidermal Necrolysis, Life Support, Iris Adhesions, Blood Creatine Phosphokinase MB Increased, Prothrombin Time Ratio Decreased, Alopecia, Rash Erythematous, Asthenia, Leukopenia
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Depakene
Dosage: 1.6 g daily
Indication: Partial Seizures
End date: 2004-11-22
Trileptal
Dosage: 600 mg, bid
Administration route: Oral
Indication: Partial Seizures
Start date: 2005-02-14
End date: 2005-02-21
Depakene
Dosage: 1 g daily
Administration route: Oral
Indication: Partial Seizures
Start date: 2004-11-23
End date: 2004-11-23
Depakene
Dosage: 1.5 g daily
Start date: 2004-11-24
End date: 2005-02-21
Aspegic 325
Indication: Influenza Like Illness
Start date: 2005-02-01
Other drugs received by patient: Rivotril
Adverse event in 20 year old male receiving Trileptal (Oxcarbazepine)
Reported by a consumer/non-health professional from France on 2007-04-27
Patient: 20 year old male, weighing 70.0 kg (154.0 pounds)
Adverse reactions / side effects: High Density Lipoprotein Increased, Blood Creatine Phosphokinase Increased, Lymphadenopathy, Corneal Neovascularisation, Skin Exfoliation, Symblepharon, Scab, Intubation, Ulcerative Keratitis, Pyrexia, Transaminases Increased, C-Reactive Protein Increased, Corneal Transplant, Dermatitis Bullous, Bone Marrow Failure, Acute Respiratory Distress Syndrome, Mucous Membrane Disorder, Thrombocytopenia, Depilation, Dysphagia, Toxic Epidermal Necrolysis, Life Support, Iris Adhesions, Blood Creatine Phosphokinase MB Increased, Prothrombin Time Ratio Decreased, Alopecia, Rash Erythematous, Asthenia, Leukopenia
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Depakene
Dosage: 1.6 g daily
Indication: Partial Seizures
End date: 2004-11-22
Trileptal
Dosage: 600 mg, bid
Administration route: Oral
Indication: Partial Seizures
Start date: 2005-02-14
End date: 2005-02-21
Depakene
Dosage: 1 g daily
Administration route: Oral
Indication: Partial Seizures
Start date: 2004-11-23
End date: 2004-11-23
Depakene
Dosage: 1.5 g daily
Start date: 2004-11-24
End date: 2005-02-21
Aspegic 325
Indication: Influenza Like Illness
Start date: 2005-02-01
Other drugs received by patient: Rivotril
Adverse event in 49 year old female receiving Trileptal (Oxcarbazepine)
Reported by a physician from Brazil on 2007-04-23
Patient: 49 year old female
Adverse reactions / side effects: Optic Nerve Disorder, Drug Ineffective, Impaired Work Ability, Chills, Fear, Visual Field Tests Abnormal, Visual Acuity Reduced, Disorientation, Headache, Speech Disorder, Diplopia, Malaise, Social Avoidant Behaviour, Tongue Disorder, Retinal Disorder, Eye Movement Disorder, Aura, Crying, Corrective Lens User, Anxiety, Visual Disturbance, Abnormal Sensation in Eye, Petit MAL Epilepsy, Feeling Abnormal, Blindness
Adverse event resulted in: disablity
Suspect drug(s):
Trileptal
Dosage: 600 mg, tid
Indication: Petit MAL Epilepsy
Start date: 2007-02-14
Trileptal
Dosage: unk, unk
Administration route: Oral
Start date: 1982-01-01
Oxcarbazepine (Auram)
Dosage: 2df/day
Other drugs received by patient: Topamax; Rivotril; Paroxetine (Pondera)
Adverse event in 10 year old male receiving Trileptal (Oxcarbazepine)
Reported by a physician from Romania on 2007-04-09
Patient: 10 year old male, weighing 28.0 kg (61.6 pounds)
Adverse reactions / side effects: Epistaxis
Adverse event resulted in: disablity
Suspect drug(s):
Trileptal (Oxcarbazepine)
Adverse event in 41 year old male receiving Trileptal (Oxcarbazepine)
Reported by a lawyer from United States on 2007-03-15
Patient: 41 year old male
Adverse reactions / side effects: Rash Generalised, Decreased Activity, Fear, Pain, Decreased Interest, Emotional Distress, Anxiety, Malaise, Asthenia, Stevens-Johnson Syndrome, Disability, Scar
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Trileptal (Oxcarbazepine)
Adverse event in 59 year old male receiving Trileptal (Oxcarbazepine)
Reported by a physician from United States on 2007-01-29
Patient: 59 year old male
Adverse reactions / side effects: Dysgeusia, Ageusia
Adverse event resulted in: disablity
Suspect drug(s):
Trileptal (Oxcarbazepine)
Other drugs received by patient: Monopril; Verapamil
Adverse event in 39 year old male receiving Trileptal (Oxcarbazepine)
Reported by a consumer/non-health professional from United States on 2007-01-05
Patient: 39 year old male, weighing 82.6 kg (181.6 pounds)
Adverse reactions / side effects: Lymphadenopathy, Rash Generalised, Drug Hypersensitivity, Pyrexia
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Tegretol
Indication: Trigeminal Neuralgia
Start date: 1999-07-01
End date: 1999-07-08
Trileptal
Start date: 2002-07-01
End date: 2002-07-02
|
